# US 2003/0211582 A1 · Human DNA Ligase III

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0211582 A1
- Document ID: US20030211582A1
- Status: Published application
- Kind: A1
- Application number: 10/464,768
- Filed: 2003-06-19
- Published: 2003-11-13
- Earliest claimed: 1995-03-31
- Inventors: Ying-Fei Wei; Guo-Liang Yu; William A. Haseltine
- Web page: https://patentgrep.com/patent/US20030211582A1

## CPC

- C12N 9/93: {Ligases (6)}
- A61K 48/00: Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C12N 2799/026: where the vector is derived from a baculovirus
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

A human DNA Ligase III polypeptide and DNA (RNA) encoding such polypeptide and a procedure for producing such polypeptide by recombinant techniques is disclosed. Also disclosed are methods for utilizing such polypeptide via gene therapy for the treatment of disorders associated with a defect in DNA Ligase III. Antagonists against such polypeptides and their use as a therapeutic to destroy unwanted cells are also disclosed. Diagnostic assays to detect mutant DNA Ligase III genes are also disclosed.

## Claims

### Claim 1

A method of producing an antibody that specifically binds the polypeptide of SEQ ID NO:2 comprising:
(a) introducing a polypeptide comprising at least 50 contiguous amino acids of SEQ ID NO:2 into an animal; and
(b) recovering said antibody.

### Claim 2 (depends on 1)

The method of claim 1 wherein the antibody binds a polypeptide consisting of amino acids 2 to 922 of SEQ ID NO:2.

### Claim 3 (depends on 1)

The method of claim 1 wherein the antibody is a polyclonal antibody.

### Claim 4 (depends on 1)

The method of claim 1 that also comprises the step of generating a hybridoma prior to recovering said antibody.

### Claim 5 (depends on 4)

The method of claim 4 wherein the antibody is a monoclonal antibody.

### Claim 6

A method of producing an antibody that specifically binds the full-length polypeptide encoded by the cDNA in ATCC Deposit No. 97052 comprising:
(a) introducing a polypeptide comprising at least 50 contiguous amino acids encoded by ATCC Deposit No. 97052 into an animal; and
(b) recovering said antibody.

### Claim 7 (depends on 6)

The method of claim 6 wherein the antibody binds a polypeptide consisting of the full-length protein encoded by the cDNA contained in ATCC Deposit No. 97052, excepting the N-terminal methionine.

### Claim 8 (depends on 6)

The method of claim 6 wherein the antibody is a polyclonal antibody.

### Claim 9 (depends on 6)

The method of claim 6 that also comprises the step of generating a hybridoma prior to recovering said antibody.

### Claim 10 (depends on 9)

The method of claim 9 wherein the antibody is a monoclonal antibody.

### Claim 11

A method of producing an antibody that specifically binds the polypeptide of SEQ ID NO:2 comprising:
(a) screening a single chain or Fab expression library to identify an antibody that specifically binds a polypeptide comprising at least 50 amino acids of SEQ ID NO:2; and
(b) recovering said antibody from said library.

### Claim 12 (depends on 11)

The method of claim 11 wherein the antibody is a single chain antibody.

### Claim 13 (depends on 11)

The method of claim 11 wherein the antibody is an Fab fragment.

### Claim 14 (depends on 11)

The method of claim 11 wherein the polypeptide comprising at least 50 amino acids of SEQ ID NO:2 consists of amino acid residues 2 to 922 of SEQ ID NO:2.

### Claim 15 (depends on 11)

The method of claim 11 wherein the polypeptide comprising at least 50 amino acids of SEQ ID NO:2 consists of amino acid residues 1 to 922 of SEQ ID NO:2.

### Claim 16

A method of producing an antibody that specifically binds the polypeptide encoded by the cDNA in ATCC Deposit No. 97052 comprising:
(a) screening a single chain or Fab expression library to identify an antibody that binds a polypeptide comprising at least 50 amino acids of the polypeptide encoded by the cDNA in ATCC Deposit No. 97052; and
(b) recovering said antibody from said library.

### Claim 17 (depends on 16)

The method of claim 16 wherein the antibody is a single chain antibody.

### Claim 18 (depends on 16)

The method of claim 16 wherein the antibody is an Fab fragment.

### Claim 19 (depends on 16)

The method of claim 16 wherein the polypeptide comprising at least 50 amino acids of the polypeptide encoded by the human cDNA in ATCC Deposit No. 97052 consists of the full-length polypeptide encoded by the cDNA in ATCC Deposit No. 97052, excepting the N-terminal methionine.

### Claim 20 (depends on 16)

The method of claim 16 wherein the polypeptide comprising at least 50 amino acids of the polypeptide encoded by the human cDNA in ATCC Deposit No. 97052 consists of the full-length polypeptide encoded by the cDNA in ATCC Deposit No. 97052.
